pharmaphorum

APRIL 26, 2021

Jolly Good has already won a “Home Healthcare Award” in a programme held by Teijin in December last year. Using technologies such as VR and AI, the company aims to accelerate human growth and social rehabilitation in medical education and provide support for people with disabilities, as well as provide treatments for mental illness.

Development 122

Development Medicine Production Marketing 122

Drug Discovery World

MAY 22, 2023

But are these price tags a barrier to access? Its subsequent success with approval in the US shows us that some drugs will be unavailable to some markets and patients for now. The fact remains that the science behind the drugs is sound, there is direct patient need, and the medical benefits are pertinent. million per dose.

Gene Therapy 52

Gene Therapy Gene Drugs Contamination 52

Drug Discovery World

NOVEMBER 9, 2023

Klaus Wagenbauer, PhD, Founder & CEO, Plectonic, on: ‘Programmable DNA-origami-based T cell engagers: PTE’. These include: Xiaole Shirley Liu, PhD, CEO, GV20 Therapeutics, on: ‘AI-based target and antibody discovery from patient tumour profiles’.

Engineer 52

Engineer Antibody Protein In-Vivo 52